The Soluble Option — Putting The Patient First When Manufacturing OSD Forms

Summary: Around 35% of the general population have difficulty swallowing! Ralph Gosden, head of product development at Catalent reveals how orally disintegrating tablet (ODT) can help and why the Zydis ODT platform is a game changer. Read this latest article from European Pharma Manufacturing to get expert insights on ODT challenges and solutions.

Click here to read article.